Sarraf Gentile LLP Announces Lawsuit Against Accretive Health, Inc.
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 04/27/12 -- A class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Accretive Health, Inc. (NYSE: AH). The action is brought on behalf of all people who purchased Accretive common stock from March 2, 2011 through April 24, 2012 (the "Class Period").
The complaint alleges that Accretive and certain of its officers and directors issued materially false and misleading statements in violation of the Securities Exchange Act of 1934 by failing to disclose that the company was violating health privacy laws, state debt collection laws and state consumer protection laws. According to the complaint, defendants' false statements caused the company's stock to trade at artificially inflated prices during the Class Period, reaching a high of $30.80 per share on August 1, 2011.
No class has yet been certified in the action. Until a class is certified, you are not represented by counsel unless you retain one. Sarraf Gentile LLP has not filed a lawsuit against the defendants.
If you are a shareholder of Accretive and want to discuss your legal rights, at no cost and without obligation, please contact Joseph Gentile at Sarraf Gentile LLP (telephone: 212-868-3610; e-mail: ).
Sarraf Gentile LLP has extensive experience litigating shareholder actions across the United States and has recovered millions of dollars on behalf of injured shareholders.
ATTORNEY ADVERTISING
Prior results to not guarantee similar outcome
Contact:
Joseph Gentile, Esq.
SARRAF GENTILE LLP
450 Seventh Avenue, Suite 1900
New York, NY 10123
T 212.868.3610
F 212.918.7967
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.04.2012 - 01:08 Uhr
Sprache: Deutsch
News-ID 140313
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 376 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sarraf Gentile LLP Announces Lawsuit Against Accretive Health, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
Sarraf Gentile LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
